Treatment of Pemphigus and Pemphigoid

The Treatment of Pemphigus and Pemphigoid PSP is working with patients, carers and health professionals to identify the unanswered questions about three auto-immune blistering diseases (bullous pemphigoid, pemphigus vulgaris and mucous membrane pemphigoid) and then prioritise those questions that they agree are the most important for research to address. Pemphigus and pemphigoid are rare autoimmune blistering diseases of the skin and/or mucous membranes. 

The PSP is being funded by Nottingham Hospitals Charity and is co-ordinated by the Centre of Evidence Based Dermatology.

The Interim prioritisation survey closed in September 2022.

Key documents

The Treatment of Pemphigus and Pemphigoid PSP Protocol